High Growth Tech Stocks In The US Market May 2025
Over the last 7 days, the United States market has risen by 2.7%, contributing to a 9.6% increase over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market trends.
Name
Revenue Growth
Earnings Growth
Growth Rating
Super Micro Computer
20.35%
33.99%
★★★★★★
Travere Therapeutics
28.65%
66.06%
★★★★★★
TG Therapeutics
26.06%
37.39%
★★★★★★
Arcutis Biotherapeutics
26.11%
58.46%
★★★★★★
Clene
62.08%
64.01%
★★★★★★
Alnylam Pharmaceuticals
23.08%
58.85%
★★★★★★
AVITA Medical
27.81%
55.17%
★★★★★★
Alkami Technology
20.71%
92.32%
★★★★★★
Ascendis Pharma
32.75%
59.64%
★★★★★★
Lumentum Holdings
21.34%
120.49%
★★★★★★
Click here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, testing, and delivering transformative medicines for genetic diseases and cancers, with a market cap of approximately $7.29 billion.
Operations: BridgeBio Pharma, Inc. generates revenue primarily from identifying and advancing transformative medicines to treat patients, reporting $127.42 million in this segment. The company is focused on addressing genetic diseases and cancers through its biopharmaceutical innovations.
BridgeBio Pharma, with its robust pipeline and strategic collaborations, exemplifies innovation in the biotech sector. Despite a challenging financial position with less than one year of cash runway and ongoing unprofitability, the company's revenue is projected to grow at 42.6% annually, outpacing the US market's 8.2%. Recent approvals for its leading drug acoramidis in multiple regions underscore its potential to address significant unmet medical needs in cardiomyopathy. These developments could catalyze future profitability, as evidenced by an expected earnings growth of 62.14% per year over the next three years.
Unlock comprehensive insights into our analysis of BridgeBio Pharma stock in this health report.
Review our historical performance report to gain insights into BridgeBio Pharma's's past performance.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kingsoft Cloud Holdings Limited is a company that offers cloud services to businesses and organizations mainly in China, with a market capitalization of approximately $3.42 billion.
Operations: Offering cloud services primarily in China, Kingsoft Cloud Holdings generates revenue from the Internet Software & Services segment, amounting to CN¥7.79 billion.
Despite recent challenges, Kingsoft Cloud Holdings is charting a path toward profitability with strategic financial maneuvers and robust revenue forecasts. The company recently raised $208.5 million through follow-on equity offerings, signaling investor confidence and bolstering its capital for future growth initiatives. With a notable improvement in its annual financials—revenue up to CNY 7.79 billion from CNY 7.05 billion last year and a reduced net loss—Kingsoft Cloud is leveraging these gains alongside an expected surge in earnings by 93.3% annually. This performance, coupled with an aggressive R&D strategy that remains central to its innovation drive, positions the firm well within the competitive tech landscape.
Dive into the specifics of Kingsoft Cloud Holdings here with our thorough health report.
Examine Kingsoft Cloud Holdings' past performance report to understand how it has performed in the past.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: VNET Group, Inc. is an investment holding company that offers hosting and related services in China, with a market capitalization of approximately $1.52 billion.
Operations: The company generates revenue primarily through hosting and related services, amounting to CN¥8.26 billion.
VNET Group's recent strategic maneuvers, including a substantial fixed-income offering of $430 million, underscore its financial agility in navigating the tech sector's complexities. This infusion is poised to bolster its R&D efforts and fuel innovations essential for sustaining its competitive edge. Impressively, VNET turned a profit this year with net income reaching CNY 183.2 million from a significant loss previously, reflecting robust operational improvements and cost efficiencies. The firm forecasts revenue growth between 10% to 13% for 2025, indicative of its resilient business model and adaptability in a dynamic market environment.
Take a closer look at VNET Group's potential here in our health report.
Assess VNET Group's past performance with our detailed historical performance reports.
Embark on your investment journey to our 236 US High Growth Tech and AI Stocks selection here.
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:BBIO NasdaqGS:KC and NasdaqGS:VNET.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Andrew Peller Reports Full Year 2025 Earnings
Revenue: CA$389.6m (up 1.0% from FY 2024). Net income: CA$11.1m (up from CA$2.85m loss in FY 2024). Profit margin: 2.9% (up from net loss in FY 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to stay flat during the next 2 years compared to a 4.6% growth forecast for the Beverage industry in North America. Performance of the market in Canada. The company's shares are up 5.9% from a week ago. Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Andrew Peller (2 are concerning) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
IOI Corporation Berhad's (KLSE:IOICORP) Intrinsic Value Is Potentially 17% Below Its Share Price
IOI Corporation Berhad's estimated fair value is RM2.99 based on 2 Stage Free Cash Flow to Equity IOI Corporation Berhad's RM3.61 share price signals that it might be 21% overvalued The RM4.07 analyst price target for IOICORP is 36% more than our estimate of fair value Today we will run through one way of estimating the intrinsic value of IOI Corporation Berhad (KLSE:IOICORP) by taking the expected future cash flows and discounting them to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (MYR, Millions) RM917.4m RM999.1m RM1.00b RM1.01b RM1.03b RM1.06b RM1.09b RM1.12b RM1.16b RM1.20b Growth Rate Estimate Source Analyst x2 Analyst x4 Analyst x4 Est @ 1.22% Est @ 1.95% Est @ 2.45% Est @ 2.81% Est @ 3.06% Est @ 3.23% Est @ 3.36% Present Value (MYR, Millions) Discounted @ 8.4% RM846 RM851 RM786 RM734 RM691 RM653 RM619 RM589 RM561 RM535 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = RM6.9b After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 3.6%. We discount the terminal cash flows to today's value at a cost of equity of 8.4%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = RM1.2b× (1 + 3.6%) ÷ (8.4%– 3.6%) = RM26b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= RM26b÷ ( 1 + 8.4%)10= RM12b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is RM19b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of RM3.6, the company appears slightly overvalued at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at IOI Corporation Berhad as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.4%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for IOI Corporation Berhad Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Weakness Dividend is low compared to the top 25% of dividend payers in the Food market. Expensive based on P/E ratio and estimated fair value. Opportunity IOICORP's financial characteristics indicate limited near-term opportunities for shareholders. Threat Dividends are not covered by cash flow. Annual earnings are forecast to decline for the next 3 years. Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Can we work out why the company is trading at a premium to intrinsic value? For IOI Corporation Berhad, we've put together three relevant factors you should assess: Risks: Every company has them, and we've spotted 2 warning signs for IOI Corporation Berhad (of which 1 is potentially serious!) you should know about. Future Earnings: How does IOICORP's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every Malaysian stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Be Sure To Check Out Able Global Berhad (KLSE:ABLEGLOB) Before It Goes Ex-Dividend
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Able Global Berhad (KLSE:ABLEGLOB) is about to trade ex-dividend in the next 3 days. Typically, the ex-dividend date is two business days before the record date, which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. Meaning, you will need to purchase Able Global Berhad's shares before the 19th of June to receive the dividend, which will be paid on the 4th of July. The company's next dividend payment will be RM00.0175 per share, on the back of last year when the company paid a total of RM0.075 to shareholders. Last year's total dividend payments show that Able Global Berhad has a trailing yield of 5.0% on the current share price of RM01.51. We love seeing companies pay a dividend, but it's also important to be sure that laying the golden eggs isn't going to kill our golden goose! As a result, readers should always check whether Able Global Berhad has been able to grow its dividends, or if the dividend might be cut. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Able Global Berhad paid out a comfortable 33% of its profit last year. Yet cash flows are even more important than profits for assessing a dividend, so we need to see if the company generated enough cash to pay its distribution. Fortunately, it paid out only 31% of its free cash flow in the past year. It's positive to see that Able Global Berhad's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut. See our latest analysis for Able Global Berhad Click here to see the company's payout ratio, plus analyst estimates of its future dividends. Stocks in companies that generate sustainable earnings growth often make the best dividend prospects, as it is easier to lift the dividend when earnings are rising. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. With that in mind, we're encouraged by the steady growth at Able Global Berhad, with earnings per share up 7.6% on average over the last five years. The company is retaining more than half of its earnings within the business, and it has been growing earnings at a decent rate. We think this is generally an attractive combination, as dividends can grow through a combination of earnings growth and or a higher payout ratio over time. Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. In the past 10 years, Able Global Berhad has increased its dividend at approximately 19% a year on average. We're glad to see dividends rising alongside earnings over a number of years, which may be a sign the company intends to share the growth with shareholders. Has Able Global Berhad got what it takes to maintain its dividend payments? Earnings per share growth has been growing somewhat, and Able Global Berhad is paying out less than half its earnings and cash flow as dividends. This is interesting for a few reasons, as it suggests management may be reinvesting heavily in the business, but it also provides room to increase the dividend in time. We would prefer to see earnings growing faster, but the best dividend stocks over the long term typically combine significant earnings per share growth with a low payout ratio, and Able Global Berhad is halfway there. There's a lot to like about Able Global Berhad, and we would prioritise taking a closer look at it. In light of that, while Able Global Berhad has an appealing dividend, it's worth knowing the risks involved with this stock. For example, we've found 1 warning sign for Able Global Berhad that we recommend you consider before investing in the business. Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
